A randomized, double blind, placebo-controlled, parallel, international multicenter study assessing the efficacy of S066913 in patients with paroxysmal atrial fibrillation
Phase of Trial: Phase II
Latest Information Update: 28 Sep 2016
At a glance
- Drugs XEN D0103 (Primary)
- Indications Paroxysmal atrial fibrillation
- Focus Therapeutic Use
- Acronyms DIAGRAF-IKur
- Sponsors Servier
- 22 Sep 2016 This trial has been completed in Netherlands (End date:2016-09-06) as per European Clinical Trials Database record.
- 02 Mar 2016 Status changed from recruiting to discontinued as reported by European Clinical Trials Database record.
- 31 Jan 2015 Status changed from planning to recruiting according to European Clinical Trials Database record.